Reynold Spector Award in Clinical Pharmacology and Translational Medicine
The Reynold Spector Award honors outstanding research bridging pharmacological science and clinical practice, presented by the American Society for Pharmacology and Experimental Therapeutics.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates: September 21, 2026
Funding Amounts: Honorific award; recognition of significant achievement; no direct grant funding specified.
Summary: Recognizes outstanding contributions in clinical pharmacology and translational medicine, honoring impactful research bridging science and clinical practice.
Key Information: Intended for investigators older than 45.
Description
The Reynold Spector Award in Clinical Pharmacology and Translational Medicine, offered by the American Society for Pharmacology and Experimental Therapeutics (ASPET), honors individuals who have made significant contributions to clinical pharmacology and the advancement of translational medicine. This prestigious award recognizes those whose work has successfully bridged the gap between pharmacological discovery and clinical application, with a focus on research and leadership that has advanced patient care and therapeutic innovation. The award is made possible by an endowment from Dr. Reynold and Mrs. Michiko Spector.
